These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22389139)

  • 1. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
    Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
    Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
    Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z
    Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1.
    Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z
    Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
    Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
    Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
    Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
    Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet.
    Epp RA; Susser SE; Morissette MP; Kehler DS; Jassal DS; Duhamel TA
    Can J Physiol Pharmacol; 2013 Jan; 91(1):80-9. PubMed ID: 23369057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats.
    Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY
    BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus.
    Oh JE; Jun JH; Hwang HJ; Shin EJ; Oh YJ; Choi YS
    Acta Diabetol; 2019 Jan; 56(1):105-114. PubMed ID: 30206697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
    Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats.
    Wang T; Qiao S; Lei S; Liu Y; Ng KF; Xu A; Lam KS; Irwin MG; Xia Z
    PLoS One; 2011; 6(8):e23967. PubMed ID: 21912612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
    Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
    Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
    Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors.
    Rabadiya S; Bhadada S; Dudhrejiya A; Vaishnav D; Patel B
    Biomed Pharmacother; 2018 Jan; 97():919-927. PubMed ID: 29136770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.